Table 1.
Patients | Gender | Tumor location | Tumor size (cm3) | Comorbid illnessa |
---|---|---|---|---|
P1 | F | RML | 21.51 | CHF, MI, colon cancer |
P2 | F | LLL | 1.57 | COPD, psoriasis |
P3 | F | RLL | 4.63 | N∕A |
P4 | M | RUL | 10.82 | COPD, HTN |
P5 | M | LLL | 25.24 | N∕A |
P6 | M | Mediastinum | 78.03 | N∕A |
P7 | M | LUL | 0.14 | COPD, CHF, MI, HTN |
P8 | F | LLL | 2.63 | AtrialFib, PMR, hyperthyroidism |
P9 | M | RML | 4.14 | Asthma, tonsillar cancer, H∕N cancer |
P10 | F | RUL | 0.67 | Breast cancer, colon cancer |
P11 | M | LUL | 0.08 | CHF, MI, COPD, HTN, PVD |
P12 | F | RUL | 2.83 | COPD |
P13 | F | RUL | 59.33 | None |
P14 | F | LUL | 2.05 | COPD, CHF, MI, PMR |
P15 | F | LLL | 5.3 | HTN |
P16 | F | LUL | 0.76 | Rectal∕colon cancer |
CHF: Congestive heart failure, COPD: Chronic obstructive pulmonary disease, HTN: hypertension, MI: Myocardial infarction (heart attack), PMR: Polymyalgia rheumatica, PVD: Peripheral vascular disease.